Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CT › Rocky Hill › NPI 1801826680
Physician

Physicians for Women's Health LLC

Physicians for Women's Health LLC was paid $57.27M by Medicaid between Jan 2018 and Dec 2024, across 147 billing codes. Its largest line is 81420, Fetal chromosomal aneuploidy genomic sequence analysis panel — 10% of everything it billed.

33Billing provider infoPHYSICIANS FOR WOMEN'S HEALTH LLC
ROCKY HILL, CT 06067
33aNPI1801826680assigned 07/04/2006
28Total paid$57.27M
24GClaims2,246,993
24DCodes billed147
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018235,843$5.10M
2019281,081$5.65M
2020278,881$5.77M
2021365,053$9.05M
2022355,994$9.70M
2023373,505$10.56M
2024incomplete356,636$11.44M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel 10% 12,634 11,382 $5.87M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 9.5% 142,121 128,603 $5.42M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 8.9% 160,344 153,831 $5.08M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 8.9% 160,156 153,703 $5.08M
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 5.3% 104,699 102,043 $3.06M
81513 3.7% 23,803 22,464 $2.12M
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 3.4% 140,281 137,026 $1.92M
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 3.1% 33,317 32,338 $1.75M
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 2.9% 79,914 76,492 $1.68M
76830 Ultrasound, transvaginal 2.7% 26,892 25,003 $1.52M
88305 Level IV - Surgical pathology, gross and microscopic examination 2.6% 22,592 18,282 $1.48M
87800 1.9% 29,234 28,099 $1.09M
135 more codes
96127 1.7% 63,682 $968K
99214 Doctor's office visit, returning patient (more involved) 1.6% 16,830 $944K
86780 1.4% 71,992 $830K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 1.4% 25,961 $797K
87660 1.3% 45,158 $766K
87480 1.3% 45,172 $765K
87510 1.3% 44,513 $761K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 1.3% 13,025 $759K
87481 1.3% 23,786 $732K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed 1.3% 3,140 $720K
76801 1.1% 5,492 $655K
59025 Fetal non-stress test 1.1% 13,837 $628K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 1.0% 10,568 $594K
86803 1.0% 47,235 $585K
87653 <1% 18,331 $571K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 6,851 $569K
87086 Culture, bacterial; quantitative colony count, urine <1% 78,266 $556K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 7,087 $552K
87340 <1% 54,646 $491K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 7,900 $451K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 64,330 $435K
76813 <1% 4,855 $350K
86762 <1% 27,975 $342K
84443 Thyroid stimulating hormone (TSH) <1% 21,608 $320K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 2,626 $307K
84702 <1% 27,350 $284K
77067 Screening mammography, bilateral, including computer-aided detection <1% 3,531 $283K
82670 <1% 11,136 $281K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 10,711 $272K
88141 <1% 23,202 $241K
83001 <1% 14,113 $235K
93976 <1% 1,718 $210K
84146 <1% 10,903 $192K
81025 <1% 35,008 $184K
86696 <1% 10,463 $180K
76376 <1% 5,425 $151K
83036 Hemoglobin; glycosylated (A1C) <1% 17,629 $149K
87625 <1% 5,007 $149K
83002 <1% 8,720 $147K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 5,949 $147K
86850 <1% 39,357 $129K
84144 <1% 6,585 $125K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 1,444 $117K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 4,355 $115K
87015 <1% 18,334 $108K
86695 <1% 8,980 $106K
82950 <1% 25,026 $105K
59400 Routine obstetric care including antepartum care, vaginal delivery, and postpartum care <1% 41 $100K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 7,644 $95K
77063 Screening digital breast tomosynthesis, bilateral <1% 3,522 $93K
86900 <1% 34,541 $88K
86901 <1% 34,209 $87K
87077 <1% 11,466 $83K
87088 <1% 11,408 $83K
82627 <1% 4,013 $82K
82951 <1% 7,299 $81K
86787 <1% 6,844 $75K
84439 <1% 9,286 $73K
85027 <1% 11,602 $67K
88142 <1% 4,443 $61K
80053 Comprehensive metabolic panel <1% 5,455 $51K
82607 <1% 3,397 $46K
80050 General health panel <1% 1,291 $46K
99385 <1% 738 $45K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 1,873 $37K
99459 <1% 2,693 $33K
82728 <1% 2,563 $32K
82746 <1% 2,229 $30K
80061 Lipid panel <1% 2,455 $30K
59514 <1% 51 $27K
83525 <1% 2,568 $27K
87147 <1% 5,471 $26K
82952 <1% 5,847 $20K
87186 <1% 2,316 $18K
99204 Doctor's office visit, new patient (more involved) <1% 169 $16K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 848 $16K
84703 <1% 2,350 $16K
93975 <1% 105 $16K
86304 <1% 841 $16K
80076 <1% 1,932 $14K
88344 <1% 198 $14K
99215 Doctor's office visit, returning patient (complex) <1% 188 $14K
99234 <1% 174 $13K
99404 <1% 157 $10K
82947 <1% 2,830 $10K
87210 <1% 1,709 $9K
76857 <1% 184 $8K
76819 Fetal biophysical profile; without non-stress testing <1% 140 $8K
84550 <1% 3,455 $7K
90651 <1% 29 $7K
80305 <1% 976 $7K
97810 <1% 581 $6K
81002 <1% 57,159 $5K
84450 <1% 3,083 $5K
36416 <1% 1,719 $5K
90686 <1% 343 $5K
82565 <1% 2,526 $5K
82272 <1% 1,633 $5K
84460 <1% 3,094 $4K
36415 Collection of venous blood by venipuncture <1% 1,420 $4K
82270 <1% 1,467 $4K
90674 <1% 197 $4K
83986 <1% 1,458 $4K
80048 Basic metabolic panel (calcium, ionized) <1% 513 $4K
82120 <1% 1,322 $4K
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 1,348 $4K
76641 <1% 45 $3K
76818 <1% 31 $3K
88307 <1% 51 $3K
83615 <1% 1,325 $3K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 569 $3K
87184 <1% 421 $3K
84520 <1% 2,113 $3K
99235 <1% 25 $3K
85018 <1% 2,366 $2K
99203 Doctor's office visit, new patient (routine) <1% 45 $2K
88112 <1% 26 $2K
90656 <1% 112 $2K
99442 <1% 30 $1K
81003 <1% 3,395 $682.33
54150 <1% 14 $626.40
58300 <1% 14 $592.41
96040 <1% 15 $344.25
90688 <1% 22 $338.96
51798 <1% 43 $249.42
88304 <1% 15 $164.23
82274 <1% 12 $149.64
G0476 Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test <1% 50 $101.10
82248 <1% 40 $91.67
81000 <1% 41 $87.04
G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination <1% 25 $48.42
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision <1% 31 $5.38
7025F 0% 860 $0.00
A4550 Surgical trays 0% 29 $0.00
0502F 0% 16 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGOTTSCHALL, DANIEL (CHIEF MEDICAL OFFICER)